Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer

BACKGROUND: Despite recent advancements, metastatic castration-resistant prostate cancer (CRPC) is not considered curative. Novel approaches for identification of therapeutic targets of CRPC are needed. METHODS: Next-generation sequencing revealed 945–1248 miRNAs from each lethal mCRPC sample. We co...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Goto, Yusuke, Kurozumi, Akira, Arai, Takayuki, Nohata, Nijiro, Kojima, Satoko, Okato, Atsushi, Kato, Mayuko, Yamazaki, Kazuto, Ishida, Yasuo, Naya, Yukio, Ichikawa, Tomohiko, Seki, Naohiko
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2017
Matèries:
Genetics & Genomics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5537499/
https://ncbi.nlm.nih.gov/pubmed/28641312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.191
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars